NHLBI

Blocking a serotonin receptor may provide a novel therapy for heart valve disease. Read More

A rare genetic syndrome provides new clues to lung scarring (pulmonary fibrosis), a potentially deadly consequence of many lung diseases. Read More

The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure. Read More

Vanderbilt University Medical Center investigators have received a $2.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to continue studying ways to improve sedation management for intensive care unit patients who are on mechanical ventilators. Read More

An inherited lung disease does not appear to have earlier onset and increased severity – a phenomenon called genetic anticipation – in successive generations. Read More

Levels of the protein NGAL may be a good predictor of worsening kidney function in patients with acute heart failure. Read More

Study adds evidence for infectious agents’ role in sarcoidosis, an inflammatory condition that can lead to respiratory failure and death. Read More

A protein normally known to promote cell death found to encourage survival of blood forming cells. Read More

New findings from Vanderbilt researchers may explain why only some individuals who have inherited mutations that increase risk for pulmonary hypertension actually develop the disease. Read More

A collaboration between Vanderbilt Pediatric researchers and the Metro Nashville Parks and Recreation Department to prevent obesity is kicking into high gear with the recruitment of 600 area familes. Read More

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity. Read More

Smoking is more detrimental to lung function in individuals with high proportions of African ancestry. Read More

A genetic variant may help keep an individual’s “good” cholesterol in check. Read More

Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help. Read More

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD. Read More

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome. Read More

A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure. Read More

Some patients may need a combo of medications to combat a condition that causes dizziness. Read More

Signaling pathway discoveries suggest ways to induce stem cells to become cardiac muscle cells, which could be useful for regenerating damaged heart muscle. Read More

Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool:… Read More